SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-009309
Filing Date
2021-05-06
Accepted
2021-05-06 16:17:42
Documents
15
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20210506.htm   iXBRL 8-K 32444
2 EX-99.1 exhibit991pressrelease05-0.htm EX-99.1 109085
  Complete submission text file 0001628280-21-009309.txt   296869

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20210506.xsd EX-101.SCH 2458
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20210506_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20210506_def.xml EX-101.DEF 1689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20210506_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20210506_pre.xml EX-101.PRE 12680
8 EXTRACTED XBRL INSTANCE DOCUMENT cort-20210506_htm.xml XML 10539
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 21898036
SIC: 2834 Pharmaceutical Preparations